Rice TW, Lumsden AB.Optimal medical management of peripheral arterial disease. Vasc Endovasc Surg. 2006;40: 312-327.
2.
Poldermans D, Bax JJ, Kertai MD, et al.Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107: 1848-1851.
3.
Durazzo AE, Machado FS, Ikeoka DT, et al.Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39: 967-975.
4.
Lindenauer PK, Pekow P, Wang K, et al.Lipid-lowering therapy and in-hospital mortality following major non-cardiac surgery. JAMA. 2004;291: 2092-2099.
5.
Paraskevas KI, Liapis CD, Hamilton G, et al.Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? Eur J Vasc Endovasc Surg. 2006;32: 286-293.
6.
Alnaeb ME, Alobaid N, Seifalian AM, et al.Statins and peripheral arterial disease: potential mechanisms and clinical benefits. Ann Vasc Surg. 2006 [In process citation].
7.
Alnaeb ME, Youssef F, Mikhailidis DP, et al.Short-term lipid-lowering treatment with atorvastatin improves renal function but not renal blood flow indices in patients with peripheral arterial disease. Angiology. 2006;57: 65-71.
8.
Giri J, McDermott MM, Greenland P, et al.Statin use and functional decline in patients with and without peripheral arterial disease. J Am Coll Cardiol. 2006;47: 998-1004.
9.
Feringa HH, van Waning VH, Bax JJ, et al.Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol. 2006;47: 1182-1187.
